GenEdit Inc. H-1B Visa Sponsorship 2026
Research and Development in Biotechnology Β· H-1B sponsor Β· FY2017β2026
π South San Francisco, CA most H-1B filings
Does GenEdit Inc. sponsor H-1B visas?
Yes. GenEdit Inc. has filed 1 H-1B LCA with the U.S. Department of Labor between FY2022 and FY2026. In FY2022 GenEdit Inc. filed 1 H-1B LCA at a median base salary of $125,000. No PERM green-card cases are on record.
It files most often for Analytical Scientist II roles, most in South San Francisco, CA.
H-1B filings
1 H-1B filing in FY2022, median base salary $125k. Too few years to chart a trend.
H-1B wage floor & filing outcomes
What this employer pays against the DOL legal minimum, how senior the roles are, and how the filings were decided
Roles they file for
Where they hire
Worker backgrounds
From green-card (PERM) cases
Sponsors H-1B workers but has few or no green-card (PERM) cases under this name, so worker backgrounds arenβt available.
Patents
- Granted
- 3
- US patents
- Published, not yet granted
- 9
- applications
- Most recent grant
- July 1, 2025
- Top area
- Macromolecular compounds obtained otherwise than by reactions2
Pay against the local market
GenEdit Inc.βs most-filed occupations and metros, FY2022. Its median base salary is 115% of the local BLS median for the same work.
| Occupation | Metro | Filings | GenEdit Inc. pay | Local BLS medianβ‘ | vs market |
|---|---|---|---|---|---|
| Chemists | San Francisco, CA | 1 | $125,000 | $109,080 | 115% |
About GenEdit Inc.
- Name (DOL filings)
- GenEdit Inc.
- Listed
- β
- Sponsoring since
- FY2022
- Main filing location
- South San Francisco, CA
- Industry (NAICS)
- Research and Development in Biotechnology
- Employees (global)
- β
- H-1B filings
- 1
- Median base
- $125,000
- R&D
- β
H-1B sponsors similar to GenEdit Inc.
| Employer | Filings, all years | Recent filings | Median base | New employment | Level III-IV roles |
|---|---|---|---|---|---|
| Adimab Service Company | 15 | 7 | $146k | 5 | β |
| Colossal Biosciences | 15 | 4 | $128k | 2 | β |
| Generation Bio Co. | 15 | 3 | $155k | 0 | β |
| Enveda Therapeutics | 14 | 6 | $184k | 2 | β |
| Hansoh Bio | 14 | 6 | $103k | 1 | β |
| Neuro42 | 14 | 4 | $124k | 2 | β |
| GenEdit Inc. | 1 | 0 | β | 0 | β |